Clinical Innovations Hires Jason Whetstone as VP of Human Resources
Experienced leader will strengthen company’s world-wide workforce
SALT LAKE CITY--(BUSINESS WIRE)-- Clinical Innovations, one of the world’s largest medical device companies focused on labor and delivery and neonatal intensive care, announced today it has hired Jason Whetstone as vice president of human resources.
A dynamic HR executive with 15 years of experience at Fortune 500 companies, including a decade providing hands-on leadership to operations and manufacturing organizations, Whetstone will be responsible for strengthening all aspects of Clinical Innovations’ workforce as the company continues its growth.
Based in Salt Lake City and owned by leading investment firm EQT, Clinical Innovations has a presence in more than 90 countries, including 85 percent of the hospitals in the U.S. and Western Europe. In 2018 alone, the company expanded operations in France, China and Australia, along with hiring a new chief financial officer and vice president of operations to support ongoing growth. The company also expanded in the United States where it now has a fully direct sales organization.
“Nothing has a greater impact on our ability to grow than our people,” said Ken Reali, president and CEO of Clinical Innovations. “Jason has a tremendous track record of working with top talent and building highly effective teams. His addition is great for our business, employees, and the thousands of physicians and families who rely on our products every day.”
Formed in 1993, Clinical Innovations develops and manufactures industry-leading products such as the ROM Plus® Rupture of Membranes Test, traxi® Panniculus Retractor and Kiwi® Vacuum-Assisted Delivery System.
Whetstone was most recently the senior director of human resources for Polaris Industries’ Engineering and Lean organizations. He previously worked in HR for General Mills for more than a decade, earning numerous company awards, and holds a bachelor’s degree and MBA from Brigham Young University.
“I’m passionate about helping organizations and individuals achieve maximum impact and am deeply honored to have that responsibility at Clinical Innovations,” Whetstone said. “This company is clearly driven by its mission, and I look forward to helping us grow even stronger in the years ahead.”
About Clinical Innovations
Clinical Innovations is one of the largest medical device companies exclusively focused on labor and delivery and neonatal intensive care. The company is a market-leader in several categories with products such as the Koala® Intrauterine Pressure Catheter, Kiwi® Vacuum-Assisted Delivery System, ROM Plus® Rupture of Membranes Test, traxi® Panniculus Retractor, ClearView® Uterine Manipulator, the babyLance™ Safety heel stick and the ebb® Complete Tamponade System. Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is an EQT portfolio company. For more information, visit clinicalinnovations.com.
EQT is a leading investment firm with approximately EUR 50 billion in raised capital across 28 funds. EQT funds have portfolio companies in Europe, Asia and the U.S. with total sales of more than EUR 19 billion and approximately 110,000 employees. EQT is an active investor and owner in the health care sector, including investments in Certara, Press Ganey, Ottobock, Sivantos, and Lima. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. For more information, visit EQTpartners.com.
Martha Arendt, Aileron Communications
Source: Clinical Innovations